Open original FDA record ↗Recall record
- FDA identifier
- Z-2602-2026
- Company in FDA record
- Abiomed, Inc.
- FDA classification date
- Jun 25, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Potential for thrombus formation during prolonged use of the introducer.
Source facts
- Action
- Abiomed notified consignees on about 05/22/2026, via letter titled "URGENT MEDICAL DEVICE RECALL (REMOVAL)." Consignees were made aware of the issue and that if thrombus formation were to occur, the user may encounter difficulty aspirating the sheath sidearm or valve and may observe thrombus in the syringe or sidearm post aspiration or around the valve post CP pump removal. They were instructed to review inventory for affected units and quarantine them, arrange for their return using the provided shipment label from Sedgwick, and complete and return the provided business response form. Consignees were also instructed to forward the notification to anyone in the facility that needs to be informed, if any of the subject products have been forwarded to another facility, contact that facility and provide them with the notification, and to post a copy of the notification in a visible area for awareness.
- Initiated
- 2026-05-22
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide - US Nationwide distribution in the states of FL, IL, MN, NJ, NY, VA and the country of Japan.
- Recall number
- Z-2602-2026
- Recall status
- Open, Classified
- CDRH record ID
- 221251
- FDA classified
- 2026-06-25
- Recall event number
- 99002